Next the capacity of Mtb and BCG RD1-recombinant strains to modulate DC phenotype upon infection was evaluated by flow cytometric measurement of co-stimulatory molecule cluster of differentiation (CD)86, the activation marker CD38, the MHC-II molecule HLA-DR and the maturation marker CD83 (Fig. 6). This evidence concerns the gene CD83 and infection.